DK1385886T3 - Fremgangsmåde til fremstilling af koncentrater af humant immunoglobulin til terapeutisk anvendelse - Google Patents

Fremgangsmåde til fremstilling af koncentrater af humant immunoglobulin til terapeutisk anvendelse

Info

Publication number
DK1385886T3
DK1385886T3 DK02727688T DK02727688T DK1385886T3 DK 1385886 T3 DK1385886 T3 DK 1385886T3 DK 02727688 T DK02727688 T DK 02727688T DK 02727688 T DK02727688 T DK 02727688T DK 1385886 T3 DK1385886 T3 DK 1385886T3
Authority
DK
Denmark
Prior art keywords
human immunoglobulin
therapeutic use
preparation
immunoglobulin concentrates
concentrates
Prior art date
Application number
DK02727688T
Other languages
English (en)
Inventor
Abdessatar Sami Chtourou
Philippe Paolantonacci
Roland Schmitthaeusler
Jacky Lirochon
Original Assignee
Fractionnement Et De Biotechno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fractionnement Et De Biotechno filed Critical Fractionnement Et De Biotechno
Application granted granted Critical
Publication of DK1385886T3 publication Critical patent/DK1385886T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK02727688T 2001-05-11 2002-04-24 Fremgangsmåde til fremstilling af koncentrater af humant immunoglobulin til terapeutisk anvendelse DK1385886T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0106234A FR2824568B1 (fr) 2001-05-11 2001-05-11 Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique

Publications (1)

Publication Number Publication Date
DK1385886T3 true DK1385886T3 (da) 2006-04-18

Family

ID=8863163

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02727688T DK1385886T3 (da) 2001-05-11 2002-04-24 Fremgangsmåde til fremstilling af koncentrater af humant immunoglobulin til terapeutisk anvendelse

Country Status (11)

Country Link
US (1) US7186410B2 (da)
EP (1) EP1385886B1 (da)
JP (1) JP4445202B2 (da)
AT (1) ATE312120T1 (da)
CA (1) CA2446704C (da)
DE (1) DE60207848T2 (da)
DK (1) DK1385886T3 (da)
ES (1) ES2254676T3 (da)
FR (1) FR2824568B1 (da)
IL (2) IL158893A0 (da)
WO (1) WO2002092632A1 (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2853551B1 (fr) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
WO2007106617A2 (en) * 2006-01-30 2007-09-20 Talecris Biotherapeutics, Inc. Method of treatment and prophylaxis of diseases related to amyloid deposition using igm
FR2899111B1 (fr) * 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament.
FR2899112B1 (fr) 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines et de fragments f (ab)'2 et/ou fab specifiques d'un arbovirus en tant que medicament.
US7794721B2 (en) * 2006-12-13 2010-09-14 Simon Michael R Synthesis of human secretory IgM and the treatment of clostridium difficile associated diseases herewith
US7597891B2 (en) * 2006-12-13 2009-10-06 Simon Michael R Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases
US8709413B2 (en) 2006-12-13 2014-04-29 Michael R. Simon Treatment of celiac disease with IgA
US8119104B2 (en) * 2006-12-13 2012-02-21 Michael R. Simon Treatment of celiac disease with IgA
FR2939667B1 (fr) 2008-12-17 2012-01-27 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo
FR2940617B1 (fr) 2008-12-30 2012-04-20 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobulines g
MX2011012576A (es) 2009-05-27 2012-05-08 Baxter Int Metodo para producir una preparacion altamente concentrada de inmunoglobulina de uso subcutaneo.
FR2949195B1 (fr) 2009-08-24 2011-10-14 Lfb Biomedicaments Poche de stockage de solution therapeutique
US8304248B2 (en) 2009-11-16 2012-11-06 Torres Anthony R Protein separation via ion-exchange chromatography and associated methods, systems, and devices
FR2952826B1 (fr) 2009-11-20 2012-04-06 Lab Francais Du Fractionnement Utilisation d'immunoglobulines polyvalentes pour traiter une cirrhose hepatique alcoolique ou metabolique
IT1397061B1 (it) 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
FR2961107B1 (fr) 2010-06-15 2012-07-27 Lab Francais Du Fractionnement Composition d'immunoglobulines humaines stabilisee
FR2962650B1 (fr) * 2010-07-19 2013-04-05 Lab Francais Du Fractionnement Composition d'immunoglobulines humaines concentrees
FR2974301B1 (fr) 2011-04-20 2013-08-23 Lab Francais Du Fractionnement Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes
FR2977893B1 (fr) * 2011-07-11 2015-02-20 Lab Francais Du Fractionnement Procede de preparation d'un concentre d'immunoglobulines polyvalentes
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
DK2820042T3 (da) 2012-02-29 2019-10-28 Baxalta GmbH Igg-stimuleret remyelinisering af perifere nerver
ES2751976T3 (es) 2012-03-09 2020-04-02 Csl Behring Ag Composiciones que comprenden inmunoglobulinas de tipo secretor
EP2636681A1 (en) * 2012-03-09 2013-09-11 CSL Behring AG Process for enriching IgA
EP2636684A1 (en) 2012-03-09 2013-09-11 CSL Behring AG Prevention of infection
JP2016509068A (ja) * 2013-02-28 2016-03-24 エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ クロマチン欠損細胞培養採取物からの抗体のクロマトグラフィー精製
EP3395423B1 (en) 2013-03-14 2023-09-20 Amgen Inc. Removal of leaked affinity purification ligand
CN105263946A (zh) * 2013-06-04 2016-01-20 新加坡科技研究局 蛋白质纯化方法
MX384222B (es) 2013-07-05 2025-03-14 Lab Francais Du Fractionnement Matriz de cromatografia de afinidad.
FR3018450B1 (fr) 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
FR3035971A1 (fr) 2015-05-07 2016-11-11 Lab Francais Du Fractionnement Composition enrichie en immunoglobulines polyclonales anti-a et/ou anti-b
CN105126100B (zh) * 2015-09-23 2021-01-26 成都蓉生药业有限责任公司 一种富含IgM的人免疫球蛋白制剂及其制备方法
EP3275897A1 (en) * 2016-07-27 2018-01-31 Biotest AG Process for preparing immunoglobulin compositions
FR3064485A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Traitement d'une infection par le virus respiratoire syncytial
FR3064484A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Composition d'immunoglobulines utiles pour traiter des infections virales
FR3064486A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Prevention d'une infection par le virus respiratoire syncytial dans les voies respiratoires superieures
CN108101981B (zh) * 2018-01-15 2019-06-04 四川远大蜀阳药业有限责任公司 一种静注免疫球蛋白的生产工艺
FR3081328B1 (fr) 2018-05-24 2021-01-01 Lab Francais Du Fractionnement Composition d'immunoglobulines humaines concentrees
EP4126930A1 (en) 2020-03-31 2023-02-08 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation from c-1 inhibitor depleted plasma
WO2025068923A2 (en) 2023-09-26 2025-04-03 Takeda Pharmaceutical Company Limited IMMUNOGLOBULIN FORMULATIONS DEPLETED IN IgA

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305870A (en) * 1979-01-31 1981-12-15 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Intravenous plasma derivatives and their production
US4272521A (en) * 1979-07-16 1981-06-09 Cutter Laboratories, Inc. Purified immune serum globulin
DE3927112C1 (da) * 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
DE59009020D1 (de) * 1990-03-22 1995-06-08 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates.
US5258177A (en) * 1991-12-10 1993-11-02 Alpha Therapeutic Corporation IgA preparation and process of making the same
FR2706466B1 (fr) * 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
US6150507A (en) * 1995-03-23 2000-11-21 Biopure Corporation Method for producing a purified hemoglobin product
US6096872A (en) * 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
JP4359352B2 (ja) * 1997-10-23 2009-11-04 田辺三菱製薬株式会社 室温保存製剤
NZ509135A (en) 1998-06-09 2002-10-25 Statens Seruminstitut A third generation intravenous immunoglobulin G (IVIG) purified using column chromatographic ion exchange methods

Also Published As

Publication number Publication date
DE60207848T2 (de) 2006-08-17
FR2824568B1 (fr) 2004-04-09
EP1385886A1 (fr) 2004-02-04
US20040132979A1 (en) 2004-07-08
ES2254676T3 (es) 2006-06-16
CA2446704A1 (fr) 2002-11-21
FR2824568A1 (fr) 2002-11-15
ATE312120T1 (de) 2005-12-15
AU2002257887A2 (en) 2002-11-25
US7186410B2 (en) 2007-03-06
IL158893A (en) 2009-08-03
CA2446704C (fr) 2013-09-24
IL158893A0 (en) 2004-05-12
JP4445202B2 (ja) 2010-04-07
WO2002092632A1 (fr) 2002-11-21
EP1385886B1 (fr) 2005-12-07
JP2005500265A (ja) 2005-01-06
DE60207848D1 (de) 2006-01-12

Similar Documents

Publication Publication Date Title
DK1385886T3 (da) Fremgangsmåde til fremstilling af koncentrater af humant immunoglobulin til terapeutisk anvendelse
DK0833649T4 (da) Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier
DK2006301T3 (da) Peptid-baseret immuniseringsterapi til behandling af atherosklerose
IL145337A0 (en) Process for partitioning of proteins
GB0100513D0 (en) Process
DK1459750T3 (da) (S,S)-rebexetin til behandling af fibromyalgi og andre somatoforme lidelser
IL157446A0 (en) Increased recovery of active proteins
NO20033548L (no) Modifiserte proteiner, designer toksiner og fremgangsmåter for fremstillingav disse
NO960772D0 (no) Naftylforbindelser og fremgangsmåte for fremstilling derav, mellomprodukter og preparater
WO2001058485A3 (en) Prophylactic and therapeutic antibodies against vaccina virus antigens
HUT77049A (hu) Katepszin-02-fehérjék, -nukleinsavak és -ellenanyagok
DK0911416T3 (da) Fremgangsmåde til fremstilling af protein
EP1348961A4 (en) PROTEIN CHIPS, METHOD OF MANUFACTURING THEREOF, AND PROBLEM SYSTEM FOR PROTEIN CHIPS AND OPERATING PROCESS FOR THE SEALING SYSTEM
DK1329462T3 (da) Fremgangsmåde til fremstilling af human serumalbumin, som inddrager opvarmningstrin
DE60141301D1 (de) Aromakonzentrate
DK1381382T3 (da) Fremgangsmåder og præparater til behandling af öjensygdomme
BR0109164A (pt) Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos
UA27997C2 (uk) Агент екстракції периплазматичного рекомбінантного білка, спосіб одержання периплазматичного рекомбінантного білка (варіанти), спосіб культивування прокаріотичного мікроорганізму
AU4876196A (en) A process for the preparation of factor ix from biological sources
DK1385993T3 (da) Fremgangsmåde til detektering og behandling af tuberøs sclerose kompleksrelaterede lidelser
AU2002359310A1 (en) Treating diseases mediated by metalloprotease-shed proteins
WO2001092321A3 (en) Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes
DK1275638T3 (da) Kombinationspræparat til behandling af immunologiske sygdomme
AU2001243404A1 (en) Methods, systems, and kits for the extracorporeal processing of blood
NZ332323A (en) Chromatographic method for removing unconventional transmissible agents from a protein solution